相关实验视频

Updated: Jul 4, 2025

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

小分子免疫调节剂作为下一代治疗质母细胞瘤的治疗方法

Somaya A Abdel-Rahman^1,2, Moustafa Gabr¹

¹Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, NY 10065, USA.

|January 26, 2024

概括

质母细胞瘤免疫疗法面临来自其免疫抑制微环境的挑战. 准免疫细胞并穿越血脑屏障的小分子提供了新的组合疗法潜力.

科学领域:

神经瘤学神经瘤学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

质母细胞瘤 (GBM) 是一种具有有限治疗选择的侵袭性脑癌.
GBM瘤微环境 (TME) 是高度免疫抑制,阻碍免疫疗法.
由于这些挑战,现有的免疫疗法表现出有限的成功.

研究的目的:

审查GBM TME在免疫逃避中的作用.
探索针对GBM的免疫调节策略.
突出小分子在GBM免疫疗法中克服血脑屏障 (BBB) 的潜力.

主要方法:

关于GBM免疫学和免疫治疗的当前文献的综述.
对GBM TME内的免疫抑制机制的分析.
评估调节瘤相关巨细胞 (TAM) 和免疫检查点的策略.
在BBB中对小分子药物输送的评估.

主要成果:

GBM的TME依赖于像M2类TAM这样的免疫抑制细胞.
将M2 TAM转换为M1表型是一种潜在的治疗策略.
BBB限制了药物输送,限制了免疫治疗的疗效.
与生物药物相比,小分子对BBB透有希望.

结论:

在GBM中准免疫检查点和TAM至关重要.
开发穿透大脑的小分子免疫调节剂是一个有希望的途径.
使用这些小分子的组合疗法可以改善GBM治疗结果.

关键词:

发现药物的发现.质母细胞瘤是一种质母细胞瘤.免疫检查点的检查点.免疫调节免疫调节免疫调节免疫抑制是一种免疫抑制.小分子的小分子.

更多相关视频

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...